T1	Disorder 15 29	critically ill
T2	Pharmacological_substance 49 65	antithrombin III
N1000 	Reference T2 MeSH:D000990	antithrombin III
T3	Disorder 69 82	severe sepsis
N1 	Reference T3 UMLS:C0243026	severe sepsis
T5	Disorder 233 246	severe sepsis
N2 	Reference T5 UMLS:C0243026	severe sepsis
T6	Disorder 251 263	septic shock
N3 	Reference T6 UMLS:C0036983	septic shock
T7	Disorder 358 370	septic shock
N4 	Reference T7 UMLS:C0036983	septic shock
T8	Pharmacological_substance 372 388	Antithrombin III
N1001 	Reference T8 MeSH:D000990	Antithrombin III
T11	Pharmacological_substance 509 525	antithrombin III
N1002 	Reference T11 MeSH:D000990	antithrombin III
T13	Disorder 617 630	severe sepsis
N5 	Reference T13 UMLS:C0243026	severe sepsis
T14	Disorder 635 647	septic shock
N6 	Reference T14 UMLS:C0036983	septic shock
T15	Disorder 735 748	severe sepsis
N7 	Reference T15 UMLS:C0243026	severe sepsis
T16	Pharmacological_substance 928 944	antithrombin III
N1003 	Reference T16 MeSH:D000990	antithrombin III
T19	Subject 995 1000	human
T23	Pharmacological_substance 1113 1129	antithrombin III
N1004 	Reference T23 MeSH:D000990	antithrombin III
T28	Pharmacological_substance 1329 1345	antithrombin III
N1005 	Reference T28 MeSH:D000990	antithrombin III
T29	Pharmacological_substance 1426 1433	heparin
N1006 	Reference T29 MeSH:D006493	heparin
T30	Pharmacological_substance 1533 1549	antithrombin III
N1007 	Reference T30 MeSH:D000990	antithrombin III
T36	Pharmacological_substance 1672 1688	antithrombin III
N1008 	Reference T36 MeSH:D000990	antithrombin III
T40	Pharmacological_substance 1754 1770	antithrombin III
N1009 	Reference T40 MeSH:D000990	antithrombin III
T43	Pharmacological_substance 1787 1794	heparin
N1010 	Reference T43 MeSH:D006493	heparin
T44	Disorder 1822 1830	bleeding
N8 	Reference T44 UMLS:C0019080	bleeding
T47	Pharmacological_substance 1865 1881	antithrombin III
N1011 	Reference T47 MeSH:D000990	antithrombin III
T49	Pharmacological_substance 1935 1951	antithrombin III
N1012 	Reference T49 MeSH:D000990	antithrombin III
T51	Disorder 2027 2040	severe sepsis
N9 	Reference T51 UMLS:C0243026	severe sepsis
T52	Disorder 2045 2057	septic shock
N10 	Reference T52 UMLS:C0036983	septic shock
T54	Pharmacological_substance 2118 2134	antithrombin III
N1013 	Reference T54 MeSH:D000990	antithrombin III
T55	Disorder 2176 2186	hemorrhage
N11 	Reference T55 UMLS:C0019080	hemorrhage
T56	Pharmacological_substance 2210 2217	heparin
N1014 	Reference T56 MeSH:D006493	heparin
T57	Pharmacological_substance 2277 2293	antithrombin III
N1015 	Reference T57 MeSH:D000990	antithrombin III
T60	Pharmacological_substance 2348 2355	heparin
N1016 	Reference T60 MeSH:D006493	heparin
T9	Subject 834 853	2314 adult patients
T10	Subject 893 897	1157
T12	Pharmacological_substance 983 990	placebo
N1017 	Reference T12 MeSH:D010919	placebo
T17	Pharmacological_substance 1172 1179	placebo
N1018 	Reference T17 MeSH:D010919	placebo
T18	Subject 219 227	patients
T21	Subject 30 37	patient
T4	Disorder 417 435	multiorgan failure
N12 	Reference T4 UMLS:C0026766	multiorgan failure
T27	Subject 603 611	patients
T31	Subject 721 729	patients
T34	Pharmacological_substance 1350 1357	placebo
N1019 	Reference T34 MeSH:D010919	placebo
T41	Speculation_cue 565 570	would
T42	Pharmacological_substance 663 670	placebo
N1020 	Reference T42 MeSH:D010919	placebo
T48	Disorder 460 472	severely ill
N13 	Reference T48 UMLS:C0231218	severely ill
T50	Subject 473 481	patients
T58	Speculation_cue 389 392	may
T62	Combination 1775 1786	concomitant
T66	Manner_cue 1798 1811	significantly
T67	Subject 2007 2021	adult patients
T69	Speculation_cue 2168 2172	risk
T70	Combination 2205 2209	with
